A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

NCT00464438 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: gatifloxacin
DRUG: moxifloxacin 0.5% eye drops

Sponsor

Allergan